Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Sponsor

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posted

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!

UK net migration in 2024 fell by half to 431,000: Official figures

Net migration to the UK dramatically decreased to 431,000 in 2024, a significant drop from...

By 0 4

Israeli embassy staff killed in Washington were a couple planning their engagement

Two Israeli embassy staffers, Sarah and Yaron, were fatally shot in Washington DC, near the...

By 0 4

Trump helps Gulf states become AI powers amid China fears

During Donald Trump's visit to Saudi Arabia, US tech firms announced AI deals worth billions,...

By 0 4

46th Asean summit in Malaysia: Key issues include US tariffs, Myanmar conflict and South China Sea

Malaysia is preparing to host the 46th Asean Summit, where leaders will address critical regional...

By 0 4

‘Legitimate aspiration’: TMC bats for J&K’s statehood, calls for empowerment of state government

By 0 4